Oncology News

Colorectal cancer incidence and mortality decreased after implementation of a national fecal immunochemical test-based screening program in the Netherlands, according to research presented at Digestive Disease Week.

When given a choice, participants preferred fecal immunochemical test-based screening for colorectal cancer compared with a blood test, according to research presented at Digestive Disease Week.

The combination of fecal immunochemical test-based colonoscopy and fecal calprotectin detected advanced colorectal neoplasia, according to a presentation at Digestive Disease Week.

In this video exclusive, Prabhleen Chahal, MD, from Cleveland Clinic, discussed a systematic review comparing long-term recurrence of benign sporadic adenomas after endoscopic and surgical ampullectomy, presented at Digestive Disease Week.

The FDA approved nivolumab as adjuvant treatment for certain patients with completely resected esophageal or gastroesophageal junction cancers, according to the agent’s manufacturer.

Transforming growth factor beta mutation biomarkers may help identify patients at high risk for cancer of the liver, pancreas and gastrointestinal system, according to data published in Gastroenterology.

The U.S. Preventive Services Task Force issued updated recommendations for colorectal cancer screening in JAMA.

American Institute for Cancer Research awarded more than $1 million worth of grants to fund research designed to improve understanding of how diet, nutrition, physical activity and body weight affect cancer prevention and survivorship.

Progress in the non-endoscopic detection for Barrett’s esophagus may lead to increased identification of those at risk for esophageal adenocarcinoma, according to opinions published in Annals of Internal Medicine.

Although patients in underrepresented groups present with worse outcomes than white patients, pancreatic cancer trials fail to represent non-white patients, according to a presentation at Digestive Diseases Week.